Trials / Completed
CompletedNCT00256802
The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography
The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography (MRA) Under Provocation With Glyceryl Trinitrate in Healthy Volunteers.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (planned)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To examine the ability of MRA to measure the effect of GTN on the intra-cranial vascular response during the GTN-induced headache in healthy volunteers.
Detailed description
The only intra cranial structures innervated by sensory nerves, and therefore a possible source of the headpain are the meninges and the large intracerebral arteries. The dilatation of the cerebral vessels may not be the origin of the head pain per se, but measurements of the intra cerebral vascular bed in the past has proven valuable in the migraine-research, and has helped elucidate the basis for the migraine aura (Olesen, Friberg et al. 1990). The effects of different signal molecules on the intra cerebral vasculature continue to be an important field in the migraine research, in the search for possible pain causing signaling molecules. Therefore we have set up at study to examine if MR-Angiography (MRA) can be used for monitoring of the vascular response after challenge with the known vasodilator GTN. This drug was chosen because it is well characterized and a large body of evidence from earlier studies could serve as background data (Thomsen 1997).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MR-angiography, GTN |
Timeline
- Start date
- 2004-06-01
- Completion
- 2005-01-01
- First posted
- 2005-11-22
- Last updated
- 2009-04-01
Source: ClinicalTrials.gov record NCT00256802. Inclusion in this directory is not an endorsement.